Primary care detection of chronic kidney disease in adults with Type-2 diabetes: The ADD-CKD study (awareness, detection and drug therapy in type 2 diabetes and chronic kidney disease)

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Szczech, Lynda A ^a   Stewart, Rebecca C ^b   Su, Hsu Lin ^c   DeLoskey, Richard J ^c   Astor, Brad C ^d   Fox, Chester H ^e   McCullough, Peter A ^f   Vassalotti, Joseph A ^b,g  

^a Durham Radiology Associates   (United States)

^b NATIONAL KIDNEY FOUNDATION   (United States)

^c 206 Carnegie Center   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGED; ALBUMINURIA; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PROTEIN URINE LEVEL; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SELF REPORT; URINALYSIS; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; AWARENESS; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; URINE;

ADOLESCENT; ADULT; AGED; ALBUMINURIA; AWARENESS; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUALITY OF LIFE; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84914703404     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110535     Document Type: Article

References (20)

1. Coresh J SE, Selvin E, Stevens LA, Manzi J, Kusek JW, et al. (2007) Prevalence of chronic kidney disease in the United States. JAMA 289: 2038-2047.
2. System USRD (2011) USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD.
3. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, et al. (2011) Temporal trends in the prevalence of diabetic Kidney Disease in the United States. JAMA 305: 2532-2539
4. KDIGO (2012) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 1-150.
5. American Diabetes Association (2012) Executive Summary: Standards of medical care in diabetes -2012. Diabetes Care 35: S4-S10
6. National Kidney Foundation (2002) K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-266.
7. Tuot DS, Platinga LC, Hsu CY, Jordan R, Burrows NR, et al. (2011) Chronic kidney disease awareness among individuals with clinical markers of kidney dysfunction. Clin J Am Soc Nephrol: 1838-1844.
8. Allen AS, Forman JP, Orav EJ, Bates DW, Denker BM, et al. (2011) Primary care management of chronic kidney disease. J Gen Intern Med: 386-392
9. United States Renal Data System (2010) USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD.
10. Burrows NR, Hora I, Cho P, Gerzoff RB, Geiss LS, et al. (2010) Incidence of End-Stage Renal Disease Attributed to Diabetes Among Persons With Diagnosed Diabetes - United States and Puerto Rico, 1996-2007. MMWR: 1361-1366.
11. US Preventive Service Task Force (2012 Aug 28) Screening for Chronic Kidney Disease: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med.
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, et al. (2009) A new equation to estimate glomerular filtration rate. Annals of Internal Medicine: 604-612
13. Bakker AJ (1999) Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration. Diabetes Care: 307-313.
14. Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, et al. (2008) Patient awareness in chronic kidney disease: trends and predictors. Arch Intern Med 168: 2268-2275.
15. Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081
16. Clark WF, Macnab JJ, Sontrop JM, Jain AK, Moist L, et al. (2011) Dipstick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol 22: 1729-1736.
17. Foley RN WC, Snyder JJ, Rule AD, Collins AJ (2011) Kidney function and risk triage in adults: threshold values and hierarchical importance. Kidney Int 79: 99-111.
18. Lewis EJ HL, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 329: 1456-1462
19. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, et al. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345: 851-860.
20. Parving HH LH, Brö chner-Mortensen J, Gomis R, Andersen S, Arner P (2001) The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 345: 870-878.